Overview
Avivit Brener practices in Tel Aviv, Israel. Brener is highly rated in 15 conditions, according to our data. Their top areas of expertise are Type 1 Diabetes (T1D), Congenital Hyperinsulinism, Diabetic Ketoacidosis, and X-Linked Hypophosphatemia.
Their clinical research consists of co-authoring 71 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Congenital HyperinsulinismBrener isDistinguished. Learn about Congenital Hyperinsulinism.
- Type 1 Diabetes (T1D)Brener isDistinguished. Learn about Type 1 Diabetes (T1D).
- Advanced
- Abdominal Obesity Metabolic Syndrome
- Camurati-Engelmann Disease
- Congenital HypothyroidismBrener isAdvanced. Learn about Congenital Hypothyroidism.
- Diabetic KetoacidosisBrener isAdvanced. Learn about Diabetic Ketoacidosis.
- Growth Hormone Deficiency (GHD)
- HypophosphatemiaBrener isAdvanced. Learn about Hypophosphatemia.
- Experienced
- Acanthosis NigricansBrener isExperienced. Learn about Acanthosis Nigricans.
- AchondroplasiaBrener isExperienced. Learn about Achondroplasia.
- AmenorrheaBrener isExperienced. Learn about Amenorrhea.
- Congenital Adrenal Hyperplasia (CAH)
- Congenital Generalized Lipodystrophy
- COVID-19Brener isExperienced. Learn about COVID-19.